However, recent studies have shown that low serum BDNF levels are associated with cognitive impairment in patients with first-episode and chronic SCZ and non-medicated patients with current depressive episodes of BD II and MDD (Yang et al., 2019; Teng et al., 2021). This evidence concerns the gene BDNF and Cognitive impairment.